Score Overview
See the full market ranking โ
Processa Pharmaceuticals Inc fundamental performance
Across Processa Pharmaceuticals Inc's full reported history, from 2017 to 2025, revenue declined from $ 5K to $ 0.00 and net income went from -$ 1M to -$ 13M. Revenue increased in 0% of the years measured; net income in 33%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 2.56 | โ |
1 Year2025-08-12 | $ 5.53 | -53.67% |
5 Years2021-08-12 | $ 2.92K | -99.91% |
10 Years2016-08-12 | $ 8.09K | -99.97% |
All Time2017-10-10 | $ 16.17K | -99.98% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2017-10-10 |
|---|---|---|---|---|---|
| Price | $ 2.56 | $ 5.53 | $ 2.92K | $ 8.09K | $ 16.17K |
| Return | โ | -53.67% | -99.91% | -99.97% | -99.98% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 14M | $ 1M |
| 2025 | $ 0.00 | -$ 13M | $ 5M |
| 2024 | $ 0.00 | -$ 11M | $ 1M |
| 2023 | $ 0.00 | -$ 11M | $ 4M |
| 2022 | $ 0.00 | -$ 27M | $ 6M |
| 2021 | $ 0.00 | -$ 11M | $ 16M |
| 2020 | $ 0.00 | -$ 19M | $ 15M |
| 2019 | $ 0.00 | -$ 3M | $ 691.54K |
| 2018 | $ 0.00 | -$ 3M | $ 1M |
| IPO2017 | $ 5K | -$ 1M | $ 2M |
Explore beyond PCSA
You're looking at Processa Pharmaceuticals Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score โ 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
